SPRYCEL vs SUTENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. SPRYCEL and SUTENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SPRYCEL	SUTENT
Rating	72/100	New
Pharmacy pays	~$839.19 /30	—
Type	RX	RX
Active ingredient	DASATINIB	SUNITINIB MALATE
Manufacturer	Bristol Myers Squibb	Cppi Cv
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Lymphoid Leukemia, Myeloid Leukemia	Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

sprycel sutent

Rating

72/100

New

Pharmacy pays

~$839.19 /30

—

Type

Active ingredient

DASATINIB

SUNITINIB MALATE

Manufacturer

Bristol Myers Squibb

Cppi Cv

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Lymphoid Leukemia, Myeloid Leukemia

Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

Frequently asked questions

What is the difference between Sprycel and Sutent?

Sprycel contains Dasatinib, while Sutent contains Sunitinib Malate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.